UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the Quarterly Period Ended March 29, 2008 |
|
|
|
or |
|
|
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-33962
COHERENT, INC.
Delaware |
|
94-1622541 |
(State or other jurisdiction of |
|
(I.R.S. Employer |
incorporation or organization) |
|
Identification No.) |
5100
Patrick Henry Drive, Santa Clara, California 95054
(Address of principal executive offices) (Zip
Code)
Registrants telephone number, including area code: (408) 764-4000
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer x |
Accelerated filer o |
Non-accelerated filer o |
Smaller reporting company o |
(do not check if a smaller reporting company) |
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares outstanding of registrants common stock, par value $.01 per share, on April 30, 2008 was 23,618,987 shares
COHERENT, INC.
INDEX
2
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This quarterly report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements included in or incorporated by reference in this quarterly report, other than statements of historical fact, are forward-looking statements. These statements are generally accompanied by words such as trend, may, will, could, would, should, expect, plan, anticipate, rely, believe, estimate, predict, intend, potential, continue, forecast or the negative of such terms, or other comparable terminology, including without limitation statements made under Future Trends, Our Strategy, discussions regarding our bookings and in Managements Discussion and Analysis of Financial Condition and Results of Operations. Forward-looking statements also include the assumptions underlying or relating to any of the foregoing statements. Actual results of Coherent, Inc. (referred to herein as the Company, we, our or Coherent) may differ significantly from those anticipated in these forward-looking statements as a result of various factors, including those discussed in the sections captioned Future Trends, Risk Factors, Key Performance Indicators, as well as any other cautionary language in this quarterly report. All forward-looking statements included in the document are based on information available to us on the date hereof. We undertake no obligation to update these forward-looking statements as a result of events or circumstances or to reflect the occurrence of unanticipated events or non-occurrence of anticipated events.
3
COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited; in thousands, except per share data)
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
March 29, 2008 |
|
March 31, 2007 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net sales |
|
$ |
155,942 |
|
$ |
152,116 |
|
$ |
300,238 |
|
$ |
299,625 |
|
Cost of sales |
|
88,818 |
|
87,646 |
|
172,620 |
|
173,181 |
|
||||
Gross profit |
|
67,124 |
|
64,470 |
|
127,618 |
|
126,444 |
|
||||
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
Research and development |
|
19,428 |
|
18,884 |
|
37,747 |
|
37,206 |
|
||||
Selling, general and administrative |
|
37,384 |
|
37,139 |
|
76,202 |
|
70,623 |
|
||||
Restructuring and other charges |
|
|
|
111 |
|
|
|
248 |
|
||||
Amortization of intangible assets |
|
2,229 |
|
1,950 |
|
4,435 |
|
3,893 |
|
||||
Total operating expenses |
|
59,041 |
|
58,084 |
|
118,384 |
|
111,970 |
|
||||
Income from operations |
|
8,083 |
|
6,386 |
|
9,234 |
|
14,474 |
|
||||
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
Interest and dividend income |
|
3,368 |
|
6,236 |
|
7,437 |
|
12,309 |
|
||||
Interest expense |
|
(184 |
) |
(1,871 |
) |
(345 |
) |
(3,653 |
) |
||||
Othernet |
|
1,079 |
|
731 |
|
3,052 |
|
1,714 |
|
||||
Total other income, net |
|
4,263 |
|
5,096 |
|
10,144 |
|
10,370 |
|
||||
Income before income taxes |
|
12,346 |
|
11,482 |
|
19,378 |
|
24,844 |
|
||||
Provision for income taxes |
|
6,221 |
|
4,200 |
|
8,524 |
|
6,804 |
|
||||
Net income |
|
$ |
6,125 |
|
$ |
7,282 |
|
$ |
10,854 |
|
$ |
18,040 |
|
|
|
|
|
|
|
|
|
|
|
||||
Net income per share: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
$ |
0.20 |
|
$ |
0.23 |
|
$ |
0.35 |
|
$ |
0.57 |
|
Diluted |
|
$ |
0.19 |
|
$ |
0.23 |
|
$ |
0.34 |
|
$ |
0.56 |
|
|
|
|
|
|
|
|
|
|
|
||||
Shares used in computation: |
|
|
|
|
|
|
|
|
|
||||
Basic |
|
31,394 |
|
31,417 |
|
31,406 |
|
31,378 |
|
||||
Diluted |
|
31,874 |
|
31,937 |
|
31,916 |
|
32,030 |
|
See Accompanying Notes to Condensed Consolidated Financial Statements
4
COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited; in thousands, except par value)
|
|
March 29, 2008 |
|
September 29, 2007 |
|
||
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
169,784 |
|
$ |
315,927 |
|
Restricted cash |
|
2,758 |
|
2,460 |
|
||
Short-term investments |
|
14,842 |
|
45,896 |
|
||
Accounts receivablenet of allowances of $2,835 and $2,918, respectively |
|
112,694 |
|
102,314 |
|
||
Inventories |
|
116,567 |
|
112,893 |
|
||
Prepaid expenses and other assets |
|
57,804 |
|
50,244 |
|
||
Deferred tax assets |
|
40,384 |
|
35,844 |
|
||
Total current assets |
|
514,833 |
|
665,578 |
|
||
Property and equipment, net |
|
107,475 |
|
104,305 |
|
||
Goodwill |
|
87,761 |
|
83,376 |
|
||
Intangible assets, net |
|
32,780 |
|
35,570 |
|
||
Other assets |
|
68,954 |
|
58,771 |
|
||
Total assets |
|
$ |
811,803 |
|
$ |
947,600 |
|
|
|
|
|
|
|
||
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
||
Current portion of long-term obligations |
|
$ |
9 |
|
$ |
9 |
|
Accounts payable |
|
33,622 |
|
27,849 |
|
||
Income taxes payable |
|
6,134 |
|
17,829 |
|
||
Other current liabilities |
|
91,337 |
|
83,058 |
|
||
Total current liabilities |
|
131,102 |
|
128,745 |
|
||
Long-term obligations |
|
19 |
|
21 |
|
||
Other long-term liabilities |
|
90,098 |
|
47,848 |
|
||
Commitments and contingencies (Note 8) |
|
|
|
|
|
||
Stockholders equity: |
|
|
|
|
|
||
Common stock, par value $.01 per share: |
|
|
|
|
|
||
Authorized500,000 shares |
|
|
|
|
|
||
Outstanding23,630 shares and 31,552 shares, respectively |
|
234 |
|
313 |
|
||
Additional paid-in capital |
|
159,422 |
|
380,516 |
|
||
Accumulated other comprehensive income |
|
102,018 |
|
70,672 |
|
||
Retained earnings |
|
328,910 |
|
319,485 |
|
||
Total stockholders equity |
|
590,584 |
|
770,986 |
|
||
Total liabilities and stockholders equity |
|
$ |
811,803 |
|
$ |
947,600 |
|
See Accompanying Notes to Condensed Consolidated Financial Statements.
5
COHERENT, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited; in thousands)
|
|
Six Months Ended |
|
||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
||
|
|
|
|
|
|
||
Cash flows from operating activities: |
|
|
|
|
|
||
Net income |
|
$ |
10,854 |
|
$ |
18,040 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
||
Depreciation and amortization |
|
12,241 |
|
12,696 |
|
||
Amortization of intangible assets |
|
4,435 |
|
3,893 |
|
||
Deferred income taxes |
|
935 |
|
(2,314 |
) |
||
(Gain) loss on disposal of property and equipment |
|
(87 |
) |
118 |
|
||
Stock-based compensation |
|
5,311 |
|
6,990 |
|
||
Excess tax benefit from stock-based compensation arrangements |
|
|
|
(77 |
) |
||
Non-cash restructuring and other (recoveries) |
|
|
|
(128 |
) |
||
Amortization of bond issue costs |
|
|
|
583 |
|
||
Other non-cash expense |
|
152 |
|
131 |
|
||
Changes in assets and liabilities, net of effect of acquisitions: |
|
|
|
|
|
||
Accounts receivable |
|
(2,211 |
) |
6,008 |
|
||
Inventories |
|
1,884 |
|
66 |
|
||
Prepaid expenses and other assets |
|
(14,402 |
) |
(16,608 |
) |
||
Other assets |
|
2,550 |
|
(2,957 |
) |
||
Accounts payable |
|
3,529 |
|
4,638 |
|
||
Income taxes payable/receivable |
|
1,764 |
|
2,117 |
|
||
Other current liabilities |
|
4,785 |
|
4,838 |
|
||
Other long-term liabilities |
|
(3,099 |
) |
1,902 |
|
||
Net cash provided by operating activities |
|
28,641 |
|
39,936 |
|
||
|
|
|
|
|
|
||
Cash flows from investing activities: |
|
|
|
|
|
||
Purchases of property and equipment |
|
(9,213 |
) |
(12,523 |
) |
||
Proceeds from dispositions of property and equipment |
|
9,853 |
|
167 |
|
||
Purchases of available-for-sale securities |
|
(530,332 |
) |
(349,530 |
) |
||
Proceeds from sales and maturities of available-for-sale securities |
|
561,386 |
|
281,170 |
|
||
Proceeds from sale of business |
|
6,519 |
|
|
|
||
Change in restricted cash |
|
(25 |
) |
(26 |
) |
||
Premiums paid for life insurance contracts |
|
|
|
(2,800 |
) |
||
Othernet |
|
804 |
|
197 |
|
||
Net cash provided by (used in) investing activities |
|
38,992 |
|
(83,345 |
) |
||
|
|
|
|
|
|
||
Cash flows from financing activities: |
|
|
|
|
|
||
Long-term debt repayments |
|
|
|
(2 |
) |
||
Repayment of capital lease obligations |
|
(6 |
) |
(2 |
) |
||
Cash overdrafts increase (decrease) |
|
(874 |
) |
909 |
|
||
Issuance of common stock under employee stock option and purchase plans |
|
1,362 |
|
3,784 |
|
||
Repurchase of common stock |
|
(228,147 |
) |
|
|
||
Collection of notes receivable from common stock |
|
|
|
324 |
|
||
Excess tax benefits from stock-based compensation arrangements |
|
|
|
77 |
|
||
Net cash provided by (used in) financing activities |
|
(227,665 |
) |
5,090 |
|
||
Effect of exchange rate changes on cash and cash equivalents |
|
13,889 |
|
4,955 |
|
||
Net decrease in cash and cash equivalents |
|
(146,143 |
) |
(33,364 |
) |
||
Cash and cash equivalents, beginning of period |
|
315,927 |
|
445,231 |
|
||
Cash and cash equivalents, end of period |
|
$ |
169,784 |
|
$ |
411,867 |
|
|
|
|
|
|
|
||
Supplemental disclosure of cash flow information: |
|
|
|
|
|
||
Cash paid during the period for: |
|
|
|
|
|
||
Interest |
|
$ |
192 |
|
$ |
3,730 |
|
Income taxes |
|
$ |
10,274 |
|
$ |
8,513 |
|
Cash received during the period for: |
|
|
|
|
|
||
Income taxes |
|
$ |
3,575 |
|
$ |
1,662 |
|
|
|
|
|
|
|
||
Noncash investing and financing activities: |
|
|
|
|
|
||
Unpaid property and equipment |
|
$ |
2,423 |
|
$ |
496 |
|
Net retirement of restricted stock awards |
|
$ |
|
|
$ |
225 |
|
See Accompanying Notes to Condensed Consolidated Financial Statements
6
COHERENT, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements and notes thereto should be read in conjunction with the Coherent, Inc. (referred to herein as the Company, we, our or Coherent) consolidated financial statements and notes thereto filed on Form 10-K for the fiscal year ended September 29, 2007. In the opinion of management, all adjustments necessary for a fair presentation have been made and include only normal recurring adjustments. Interim results of operations are not necessarily indicative of results to be expected for the year. Our fiscal year ends on the Saturday closest to September 30. Fiscal years 2008 and 2007 include 52 weeks each.
2. RECENT ACCOUNTING STANDARDS
In June 2006, the Financial Accounting Standards Board (FASB) issued Financial Interpretation No. (FIN) 48, Accounting for Uncertainty in Income Taxes, (FIN 48) which clarifies the accounting for uncertainty in income taxes recognized in an enterprises financial statements in accordance with Statement of Financial Accounting Standards (SFAS) No.109, Accounting for Income Taxes. FIN 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. It also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. In addition, in May 2007, the FASB issued FASB Staff Position No. FIN 48-1, Definition of Settlement in FASB Interpretation No. 48,(FSP FIN 48-1) to amend FIN 48 by providing that previously unrecognized tax benefits can be recognized when the tax positions are effectively settled upon examination by a taxing authority. According to FSP FIN 48-1, an enterprises tax position will be considered effectively settled if the taxing authority has completed its examination, the enterprise does not plan to appeal, and the possibility is remote that the taxing authority would reexamine the tax position in the future. We adopted FIN 48 and FSP FIN 48-1 for our fiscal year 2008 beginning September 30, 2007. See Note 12, Income Taxes for additional information, including the effects of adoption on the Companys Condensed Consolidated Financial Statements.
In June 2006, the FASB ratified the consensus on Emerging Issues Task Force (EITF) Issue No. 06-3, How Taxes Collected from Customers and Remitted to Governmental Authorities Should Be Presented in the Income Statement (EITF 06-3) which requires a policy be adopted to present externally imposed taxes on revenue producing transactions on either a gross or net basis. Coherents policy is to present such taxes on a gross basis. Gross or net presentation may be elected for each different type of tax, but similar taxes should be presented consistently. Taxes within the scope of this issue would include taxes that are imposed on a revenue transaction between a seller and a customer. We adopted EITF 06-3 for our fiscal year beginning September 30, 2007. The adoption of EITF 06-3 did not have a material impact on our consolidated financial statements.
In December 2007, the FASB issued SFAS No. 141 (revised 2007) Business Combinations (SFAS 141(R)). SFAS 141(R) retains the fundamental requirements of the original pronouncement requiring that the purchase method be used for all business combinations. SFAS 141(R) defines the acquirer as the entity that obtains control of one or more businesses in the business combination, establishes the acquisition date as the date that the acquirer achieves control and requires the acquirer to recognize the assets acquired, liabilities assumed and any noncontrolling interest at their fair values as of the acquisition date. SFAS 141(R) also requires that acquisition related costs be recognized separately from the acquisition. SFAS 141(R) is effective for us for acquisitions after the beginning of our fiscal year 2010.
In September 2006, the FASB issued Statement of Financial Accounting Standards No. 157, Fair Value Measurements (SFAS 157). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. SFAS 157 is effective for us for interim periods within our fiscal year beginning September 28, 2008. We are currently assessing the
7
impact that the adoption of SFAS 157 will have on our consolidated financial position and results of operations. In February 2008, the FASB issued FASB Staff Position FAS 157-2, Effective Date of FASB Statement No. 157 which delayed the effective date of SFAS No. 157 for all non-financial assets and liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis, until January 1, 2009. We have not yet determined the impact that the implementation of SFAS No. 157 will have on our non-financial assets and liabilities; however we do not anticipate it to significantly impact our consolidated financial statements.
In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (SFAS 159). SFAS 159 expands the use of fair value accounting but does not affect existing standards, which require assets or liabilities to be carried at fair value. Under SFAS 159, a company may elect to use fair value to measure certain financial assets and financial liabilities, on an instrument-by-instrument basis. If the fair value option is elected, unrealized gains and losses on existing items for which fair value has been elected are reported as a cumulative adjustment to beginning retained earnings. Subsequent to the adoption of SFAS 159, changes in fair value are recognized in earnings. SFAS 159 is effective for us for our fiscal year beginning September 28, 2008 with earlier adoption permitted. We have elected not to early adopt and are currently assessing the impact that the adoption of SFAS 159 will have on our consolidated financial position and results of operations.
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities an amendment of SFAS No. 133. This statement changes the disclosure requirements for derivative instruments and hedging activities. SFAS No. 161 requires us to provide enhanced disclosures about (a) how and why we use derivative instruments, (b) how derivative instruments and related hedged items are accounted for under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities, and its related interpretations, and (c) how derivative instruments and related hedged items affect our financial position, financial performance, and cash flows. SFAS No. 161 is effective for our interim period beginning December 28, 2008. We are currently assessing the impact that the adoption of SFAS No. 161 will have on our consolidated financial position, results of operations and cash flows.
3. REVENUE RECOGNITION
We recognize revenue when all four revenue recognition criteria have been met: persuasive evidence of an arrangement exists, the product has been delivered or the service has been rendered, the price is fixed or determinable and collection is probable. Revenue from product sales is recorded when all of the foregoing conditions are met and risk of loss and title passes to the customer. Our products typically include a one-year warranty and the estimated cost of product warranty claims (based on historical experience) is recorded at the time the sale is recognized. Sales to customers are generally not subject to any price protection or return rights.
The vast majority of our sales are made to original equipment manufacturers (OEMs), distributors, resellers and end-users in the non-scientific market. Sales made to these customers do not require installation of the products by us and are not subject to other post-delivery obligations, except in occasional instances where we have agreed to perform installation or provide training. In those instances, we defer revenue related to installation services or training until these services have been rendered. We allocate revenue from multiple element arrangements to the various elements based upon relative fair values, which is determined based on the price charged for each deliverable on a standalone basis.
Our sales to distributors, resellers and end-user customers typically do not have customer acceptance provisions and only certain of our sales to OEM customers have customer acceptance provisions. Customer acceptance is generally limited to performance under our published product specifications. For the few product sales that have customer acceptance provisions because of other than published specifications, (1) the products are tested and accepted by the customer at our site or by the customers acceptance of the results of our testing program prior to shipment to the customer, or (2) the revenue is deferred until customer acceptance occurs.
Sales to end-users in the scientific market typically require installation and, thus, involve post-delivery obligations; however, our post-delivery installation obligations are not essential to the functionality of our products. We defer revenue related to installation services until completion of these services.
For most products, training is not provided; therefore, no post-delivery training obligation exists. However, when training is provided to our customers, it is typically priced separately and is recognized as revenue after these services have been provided.
4. SHORT-TERM INVESTMENTS
We consider all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Marketable short-term investments in debt securities are classified and accounted for as available-for-sale securities and are valued based on quoted market prices. Investments classified as available-for-sale are reported at fair value with unrealized gains and losses, net of related income taxes, recorded as a separate component of other comprehensive income (OCI) in stockholders equity until realized. Interest and amortization of premiums and discounts for debt securities are included in interest income. Gains and losses on securities sold are determined based on the specific identification method and are included in other income (expense).
8
|
|
March 29, 2008 |
|
||||||||||
|
|
Cost Basis |
|
Unrealized |
|
Unrealized |
|
Fair Value |
|
||||
Cash and cash equivalents |
|
$ |
172,542 |
|
$ |
|
|
$ |
|
|
$ |
172,542 |
|
Less: restricted cash |
|
|
|
|
|
|
|
(2,758 |
) |
||||
|
|
|
|
|
|
|
|
$ |
169,784 |
|
|||
Short-term investments: |
|
|
|
|
|
|
|
|
|
||||
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
||||
U.S. Treasury and agency obligations |
|
$ |
6,641 |
|
$ |
137 |
|
|
|
$ |
6,778 |
|
|
State and municipal obligations |
|
925 |
|
1 |
|
|
|
926 |
|
||||
Corporate notes and obligations |
|
7,157 |
|
66 |
|
(85 |
) |
7,138 |
|
||||
Total short-term investments |
|
$ |
14,723 |
|
$ |
204 |
|
$ |
(85 |
) |
$ |
14,842 |
|
|
|
September 29, 2007 |
|
||||||||||
|
|
Cost Basis |
|
Unrealized
|
|
Unrealized
|
|
Fair Value |
|
||||
Cash and cash equivalents |
|
$ |
318,352 |
|
$ |
35 |
|
$ |
|
|
$ |
318,387 |
|
Less: restricted cash |
|
|
|
|
|
|
|
(2,460 |
) |
||||
|
|
|
|
|
|
|
|
$ |
315,927 |
|
|||
Short-term investments: |
|
|
|
|
|
|
|
|
|
||||
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
||||
U.S. Treasury and agency obligations |
|
$ |
6,036 |
|
$ |
7 |
|
$ |
|
|
$ |
6,043 |
|
Corporate notes and obligations |
|
39,740 |
|
132 |
|
(19 |
) |
39,853 |
|
||||
Total short-term investments |
|
$ |
45,776 |
|
$ |
139 |
|
$ |
(19 |
) |
$ |
45,896 |
|
At March 29, 2008, $2.8 million of cash was restricted for remaining close out costs associated with our purchase of the remaining outstanding shares of Lambda Physik. At September 29, 2007, $2.5 million of cash was restricted for remaining close out costs associated with our purchase of the remaining outstanding shares of Lambda Physik.
5. INTANGIBLE ASSETS
The changes in the carrying amount of goodwill by segment for the period from September 29, 2007 to March 29, 2008 are as follows (in thousands):
|
|
Commercial |
|
Specialty |
|
Total |
|
|||
Balance as of September 29, 2007 |
|
$ |
24,091 |
|
$ |
59,285 |
|
$ |
83,376 |
|
Translation adjustments and other |
|
176 |
|
4,209 |
|
4,385 |
|
|||
Balance as of March 29, 2008 |
|
$ |
24,267 |
|
$ |
63,494 |
|
$ |
87,761 |
|
Components of our amortizable intangible assets are as follows (in thousands):
|
|
March 29, 2008 |
|
September 29, 2007 |
|
||||||||||||||
|
|
Gross |
|
Accumulated |
|
Net |
|
Gross |
|
Accumulated |
|
Net |
|
||||||
Existing technology |
|
$ |
55,968 |
|
$ |
(30,983 |
) |
$ |
24,985 |
|
$ |
54,091 |
|
$ |
(26,955 |
) |
$ |
27,136 |
|
Patents |
|
11,306 |
|
(8,217 |
) |
3,089 |
|
10,184 |
|
(6,943 |
) |
3,241 |
|
||||||
Drawings |
|
1,544 |
|
(1,544 |
) |
|
|
1,390 |
|
(1,390 |
) |
|
|
||||||
Order backlog |
|
5,431 |
|
(5,408 |
) |
23 |
|
4,907 |
|
(4,864 |
) |
43 |
|
||||||
Customer lists |
|
5,631 |
|
(3,066 |
) |
2,565 |
|
5,366 |
|
(2,562 |
) |
2,804 |
|
||||||
Trade name |
|
4,139 |
|
(2,150 |
) |
1,989 |
|
3,754 |
|
(1,751 |
) |
2,003 |
|
||||||
Non-compete agreement |
|
2,581 |
|
(2,452 |
) |
129 |
|
2,408 |
|
(2,065 |
) |
343 |
|
||||||
Total |
|
$ |
86,600 |
|
$ |
(53,820 |
) |
$ |
32,780 |
|
$ |
82,100 |
|
$ |
(46,530 |
) |
$ |
35,570 |
|
9
Amortization expense for intangible assets for the six months ended March 29, 2008 was $4.4 million. At March 29, 2008, estimated amortization expense for the remainder of fiscal 2008, the next five succeeding fiscal years and all fiscal years thereafter are as follows (in thousands):
|
|
Estimated |
|
|
2008 (remainder) |
|
$ |
4,326 |
|
2009 |
|
8,287 |
|
|
2010 |
|
6,804 |
|
|
2011 |
|
5,323 |
|
|
2012 |
|
3,509 |
|
|
2013 |
|
2,097 |
|
|
Thereafter |
|
2,434 |
|
|
Total |
|
$ |
32,780 |
|
6. BALANCE SHEET DETAILS
Inventories consist of the following (in thousands):
|
|
March 29, |
|
September 29, |
|
||
Purchased parts and assemblies |
|
$ |
32,141 |
|
$ |
29,786 |
|
Work-in-process |
|
46,370 |
|
44,368 |
|
||
Finished goods |
|
38,056 |
|
38,739 |
|
||
Inventories |
|
$ |
116,567 |
|
$ |
112,893 |
|
Prepaid expenses and other assets consist of the following (in thousands):
|
|
March 29, |
|
September 29, |
|
||
Prepaid and refundable income taxes |
|
$ |
16,738 |
|
$ |
8,616 |
|
Prepaid expenses and other |
|
41,066 |
|
41,628 |
|
||
Total prepaid expenses and other assets |
|
$ |
57,804 |
|
$ |
50,244 |
|
Other assets consist of the following (in thousands):
|
|
March 29, |
|
September 29, |
|
||
Assets related to deferred compensation arrangements |
|
$ |
28,626 |
|
$ |
30,706 |
|
Deferred tax assets |
|
37,454 |
|
25,165 |
|
||
Other assets |
|
2,874 |
|
2,900 |
|
||
Total other assets |
|
$ |
68,954 |
|
$ |
58,771 |
|
Other current liabilities consist of the following (in thousands):
|
|
March 29, |
|
September 29, |
|
||
Accrued payroll and benefits |
|
$ |
29,202 |
|
$ |
28,247 |
|
Accrued expenses and other |
|
13,856 |
|
18,471 |
|
||
Reserve for warranty |
|
13,790 |
|
13,660 |
|
||
Other taxes payable |
|
20,687 |
|
9,840 |
|
||
Deferred income |
|
11,435 |
|
10,496 |
|
||
Customer deposits |
|
2,367 |
|
1,868 |
|
||
Accrued restructuring charges |
|
|
|
476 |
|
||
Total other current liabilities |
|
$ |
91,337 |
|
$ |
83,058 |
|
We provide warranties on certain of our product sales (generally one year) and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires us to make estimates of product return rates and expected costs to repair or replace the products under warranty. We currently establish warranty reserves
10
based on historical warranty costs for each product line. If actual return rates and/or repair and replacement costs differ significantly from our estimates, adjustments to cost of sales may be required in future periods.
Components of the reserve for warranty costs during the first six months of fiscal 2008 and 2007 were as follows (in thousands):
|
|
Six Months Ended |
|
||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
||
Beginning balance |
|
$ |
13,660 |
|
$ |
11,462 |
|
Additions related to current period sales |
|
10,571 |
|
11,000 |
|
||
Warranty costs incurred in the current period |
|
(11,099 |
) |
(9,672 |
) |
||
Adjustments to accruals related to prior period sales |
|
658 |
|
217 |
|
||
Ending balance |
|
$ |
13,790 |
|
$ |
13,007 |
|
Other long-term liabilities consist of the following (in thousands):
|
|
March 29, 2008 |
|
September 29, 2007 |
|
||
Deferred compensation |
|
$ |
28,654 |
|
$ |
31,336 |
|
Long-term taxes payable |
|
39,327 |
|
|
|
||
Deferred tax liabilities |
|
15,042 |
|
10,433 |
|
||
Deferred income |
|
1,737 |
|
1,585 |
|
||
Asset retirement obligations liability |
|
1,432 |
|
1,256 |
|
||
Other long-term liabilities |
|
3,906 |
|
3,238 |
|
||
Total other long-term liabilities |
|
$ |
90,098 |
|
$ |
47,848 |
|
The following table reconciles changes in our asset retirement obligations liability, which is reported in other long-term liabilities on our condensed consolidated balance sheets (in thousands):
|
|
Six Months Ended |
|
||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
||
Beginning balance |
|
$ |
1,256 |
|
$ |
1,765 |
|
Adjustment to asset retirement obligations recognized |
|
(16 |
) |
(7 |
) |
||
Accretion recognized |
|
34 |
|
75 |
|
||
Changes due to foreign currency exchange |
|
158 |
|
114 |
|
||
Ending balance |
|
$ |
1,432 |
|
$ |
1,947 |
|
7. STOCK-BASED COMPENSATION
Stock-Based Benefit Plans
We have two Stock Option Plans for which all service providers are eligible participants and a Directors Stock Option Plan for which only non-employee directors are eligible participants. The Directors Stock Option Plan is designed to work automatically without administration, however to the extent administration is necessary, it will be performed by the Board of Directors or a committee thereof. Under these three plans, we may grant options to purchase up to an aggregate of 5,500,000, 6,300,000 and 677,000 shares of common stock, respectively of which none, 3,000,983 and 153,000 shares, respectively, remain available for grant at March 29, 2008. Employee options are generally exercisable between two to four years from the grant date at a price equal to the fair market value of the common stock on the date of the grant and generally vest 25% to 50% annually. We settle stock option exercises with newly issued shares of common stock. Grants under employee plans expire six years from the original grant date, unless otherwise determined by the Board or a committee thereof, up to a maximum of ten years. Director options are automatically granted to our non-employee directors. Such directors initially receive a stock option for 24,000 shares exercisable over a three-year period and an award of restricted stock units of 2,000 shares which vest at the end of three years. Additionally, the non-employee directors receive an annual grant of 6,000 shares exercisable as to 50% of the shares on the day prior to each of the next two annual stockholder meetings. Grants under director plans expire ten years from the original grant date. In addition, each non-employee director receives an annual grant of 2,000 shares of restricted stock units that vest on the day prior to the annual stockholder meeting held in the third calendar year following the date of grant.
11
Restricted stock awards, including restricted stock units granted under our Stock Option Plans are independent of option grants and are subject to restrictions. At March 29, 2008, we had 452,515 unvested shares of restricted stock, including 125,675 performance-based restricted stock awards and units, all of which are subject to forfeiture if employment terminates prior to the release of restrictions. During this period, ownership of the shares cannot be transferred. The service-based restricted awards generally vest three years from the date of grant and the restricted stock units vest annually over three years. The performance-based restricted stock awards are generally subject to annual vesting over three years depending upon the achievement of performance measurements tied to the Companys internal metrics for revenue growth and adjusted EBITDA. The number of shares earned can range from 0% to 200% of the grant target for 2008. The Company granted performance-based restricted stock units during this quarter which have a single vesting measurement date of November 14, 2010, which vest as to anywhere between 0 and 300% of the targeted amount based upon achievement by the Company of (a) an annual revenue threshold amount and (b) adjusted EBITDA targets. Shares of restricted stock (not including performance-based restricted stock or restricted stock units) have the same cash dividend and voting rights as other common stock and are considered to be currently issued and outstanding. The cost of the awards, determined to be the fair market value of the shares at the date of grant, is expensed ratably over the period the restrictions lapse.
We have an Employee Stock Purchase Plan (ESPP) whereby eligible employees may authorize payroll deductions of up to 10% of their regular base salary to purchase shares at the lower of 85% of the fair market value of the common stock on the date of commencement of the offering or on the last day of the six-month offering period. At March 29, 2008, 224,536 shares of our common stock were reserved for future issuance under the plan.
In the second quarter of fiscal 2007, the ESPP was suspended and employee contributions made to the ESPP were returned while a voluntary review of our historical stock option practices was conducted. The ESPP was reopened with an 8 month offering period ending October 31, 2008 and employees began making contributions during the second quarter of fiscal 2008.
SFAS 123(R)
In accordance with the fair value recognition provisions of SFAS No. 123 (Revised 2004), Share-Based Payment, (SFAS 123(R)), we recognize compensation expense for all share-based payment awards on a straight-line basis over the respective requisite service period of the awards.
Determining Fair Value
Valuation and amortization methodWe estimate the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula and a single option award approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period.
Expected TermThe expected term represents the period that our stock-based awards are expected to be outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards.
Expected VolatilityOur computation of expected volatility is based on a combination of historical volatility and market-based implied volatility.
Risk-Free Interest RateThe risk-free interest rate used in the Black-Scholes-Merton valuation method is based on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term.
Expected DividendThe expected dividend assumption is based on our current expectations about our anticipated dividend policy.
The fair values of our stock options granted to employees and shares purchased under the stock purchase plan for the three and six months ended March 29, 2008 and March 31, 2007 were estimated using the following weighted-average assumptions:
|
|
Employee Stock Option Plans |
|
Employee Stock Purchase Plans |
|
||||||||||||||||||||
|
|
Three Months Ended |
|
Six Months Ended |
|
Three Months Ended |
|
Six Months Ended |
|
||||||||||||||||
|
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
||||||||
Expected life in years |
|
3.1 |
|
|
|
3.5 |
|
4.4 |
|
0.7 |
|
|
|
0.7 |
|
0.5 |
|
||||||||
Expected volatility |
|
29.5 |
% |
|
% |
29.5 |
% |
34.2 |
% |
31.9 |
% |
|
% |
31.9 |
% |
29.0 |
% |
||||||||
Risk-free interest rate |
|
2.1 |
% |
|
% |
3.9 |
% |
4.7 |
% |
1.8 |
% |
|
% |
1.8 |
% |
5.1 |
% |
||||||||
Expected dividends |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average fair value |
|
$ |
6.47 |
|
$ |
|
|
$ |
8.78 |
|
$ |
12.04 |
|
$ |
7.31 |
|
$ |
|
|
$ |
7.31 |
|
$ |
8.43 |
|
(1) During the second quarter of fiscal 2007, the stock purchase plan was suspended and employee contributions were returned while a voluntary review of our historical stock option practices was conducted. The ESPP reopened in March 2008.
12
Stock Compensation Expense
The following table shows total stock-based compensation expense included in the condensed consolidated statements of operations for the three and six months ended March 29, 2008 and March 31, 2007 (in thousands):
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
March 29, 2008 |
|
March 31, 2007 |
|
||||
Cost of sales |
|
$ |
759 |
|
$ |
667 |
|
$ |
1,144 |
|
$ |
1,103 |
|
Research and development |
|
808 |
|
739 |
|
1,127 |
|
1,299 |
|
||||
Selling, general and administrative |
|
3,382 |
|
2,349 |
|
5,383 |
|
4,844 |
|
||||
Income tax benefit |
|
(1,215 |
) |
(1,272 |
) |
(1,987 |
) |
(2,573 |
) |
||||
|
|
$ |
3,734 |
|
$ |
2,483 |
|
$ |
5,667 |
|
$ |
4,673 |
|
During the three and six months ended March 29, 2008, $0.4 million and $0.6 million, respectively, for all stock plans was capitalized into inventory, $0.3 million and $0.5 million, respectively, was amortized to cost of sales and $0.4 million remained in inventory at March 29, 2008. As required by SFAS 123(R), management made an estimate of expected forfeitures and is recognizing compensation costs only for those equity awards expected to vest.
At March 29, 2008, the total compensation cost related to unvested stock-based awards granted to employees under the Companys stock option plans but not yet recognized was approximately $13.1 million, net of estimated forfeitures of $0.8 million. This cost will be amortized on a straight-line basis over a weighted-average period of approximately 2.0 years and will be adjusted for subsequent changes in estimated forfeitures.
In accordance with SFAS 123(R), the cash flows resulting from excess tax benefits (tax benefits related to the excess of proceeds from an employees exercises of stock options over the stock-based compensation cost recognized for those options) are classified as financing cash flows. During the first six months of fiscal 2008 and fiscal 2007, we recorded none and less than $0.1 million, respectively, of excess tax benefits as cash flows from financing activities.
Stock Options & Awards Activity
The following is a summary of option activity for our Stock Option Plans (in thousands, except per share amounts and remaining contractual term in years):
|
|
Number of |
|
Weighted |
|
Weighted |
|
Aggregate |
|
||
Outstanding at September 30, 2007 |
|
3,196 |
|
$ |
28.54 |
|
|
|
|
|
|
Granted |
|
852 |
|
32.50 |
|
|
|
|
|
||
Exercised |
|
(60 |
) |
22.50 |
|
|
|
|
|
||
Forfeitures |
|
(66 |
) |
33.00 |
|
|
|
|
|
||
Expirations |
|
(380 |
) |
31.21 |
|
|
|
|
|
||
Outstanding at March 29, 2008 |
|
3,542 |
|
$ |
29.23 |
|
3.3 |
|
$ |
5,616 |
|
|
|
|
|
|
|
|
|
|
|
||
Vested and expected to vest at March 29, 2008 |
|
3,527 |
|
$ |
29.22 |
|
3.3 |
|
$ |
5,616 |
|
|
|
|
|
|
|
|
|
|
|
||
Exercisable at March 29, 2008 |
|
2,498 |
|
$ |
27.78 |
|
2.4 |
|
$ |
5,616 |
|
13
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock for the 1.2 million options that were in-the-money at March 29, 2008. During the second quarter of fiscal 2008, the aggregate intrinsic value of options exercised under the Companys stock option plans was $0.4 million, determined as of the date of option exercise. There were no options that were exercised under the Companys stock option plans during the first fiscal quarter of 2008, therefore there was no intrinsic value realized in that period. During the first quarter of fiscal 2007, the aggregate intrinsic value of options exercised under the Companys stock option plans was $0.5 million, determined as of the date of option exercise. There were no options exercised during second quarter of fiscal 2007. The following table summarizes our restricted stock award activity, including restricted stock units, for the first six months of fiscal 2008 (in thousands, except per share amounts):
|
|
Number of |
|
Weighted |
|
|
Nonvested stock at September 30, 2007 |
|
261 |
|
$ |
33.02 |
|
Granted |
|
258 |
|
28.68 |
|
|
Vested |
|
|
|
|
|
|
Forfeited |
|
(67 |
) |
33.34 |
|
|
Nonvested stock at March 29, 2008 |
|
452 |
|
$ |
30.54 |
|
8. COMMITMENTS AND CONTINGENCIES
We are subject to legal claims and litigation arising in the ordinary course of business, such as product liability, employment or intellectual property claims, including, but not limited to, the matters described below. The outcome of any such matters is currently not determinable. Although we do not expect that such legal claims and litigation will ultimately have a material adverse effect on our consolidated financial position or results of operations, an adverse result in one or more matters could negatively affect our results in the period in which they occur.
Derivative LawsuitsBetween February 15, 2007 and March 2, 2007, three purported shareholder derivative lawsuits were filed in the United States District Court for the Northern District of California against certain of Coherents current and former officers and directors. Coherent is named as a nominal defendant. The complaints generally allege that the defendants breached their fiduciary duties and violated the securities laws in connection with the granting of stock options, the accounting treatment for such grants, and the issuance of allegedly misleading public statements and stock sales by certain of the individual defendants. On May 29, 2007, these lawsuits were consolidated under the caption In re Coherent, Inc. Shareholder Derivative Litigation, Lead Case No. C-07-0955-JF (N.D. Cal.). On June 25, 2007, plaintiffs filed an amended consolidated complaint. The consolidated complaint asserts causes of action for alleged violations of federal securities laws, violations of California securities laws, breaches of fiduciary duty and/or aiding and abetting breaches of fiduciary duty, abuse of control, gross mismanagement, constructive fraud, corporate waste, unjust enrichment, insider selling and misappropriation of information. The consolidated complaint seeks, among other relief, disgorgement and damages in an unspecified amount, an accounting, rescission of allegedly improper stock option grants, punitive damages and attorneys fees and costs.
The Companys Board of Directors has appointed a Special Litigation Committee (SLC) comprised of independent director Sandeep Vij to investigate and evaluate the claims asserted in the derivative litigation and to determine what action(s) should be taken with respect to the derivative litigation. The SLCs investigation is ongoing.
Securities and Exchange Commission InquiryIn 2006, the Company was advised that the San Francisco District Office of the Securities and Exchange Commission was conducting an informal inquiry relating to the Companys past granting of stock options. The Company is cooperating fully with the inquiry.
14
Income Tax AuditsThe Internal Revenue Service (IRS) is conducting an audit of our 2003 and 2004 tax returns. The IRS has issued a number of Notices of Proposed Adjustments to these returns. Among other items, the IRS has challenged our research and development credits and our extraterritorial income (ETI) exclusion. We have agreed to the various adjustments proposed by the IRS and we believe that we have adequately provided for these exposures and any other items identified by the IRS as a result of the audit of these tax years. As part of its audit of our 2003 and 2004 years, the IRS has requested information related to our stock option investigation and we intend to comply with this request and address any issues that are raised in a timely manner. The IRS has also indicated that it may consider an audit of our 2005 and 2006 tax returns and has requested stock option investigation information for these years.
The IRS is also auditing the research and development credits generated in the years 1999 through 2001 and carried forward to future tax years. We believe that we have adequately provided for any adjustments that may be proposed by the IRS related to these credits.
The German tax authorities are conducting an audit of our subsidiary in Göttingen for the tax years 1999 through 2005. We believe that we have adequately provided for any adjustments that may be proposed by the German tax authorities.
9. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The components of comprehensive income (loss), net of income taxes, are as follows (in thousands):
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
||||
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
6,125 |
|
$ |
7,282 |
|
$ |
10,854 |
|
$ |
18,040 |
|
|
|
|
|
|
|
|
|
|
|
||||
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
|
||||
Translation adjustment |
|
28,028 |
|
4,279 |
|
31,214 |
|
11,106 |
|
||||
Net gain (loss) on derivative instruments, net of taxes |
|
2 |
|
(27 |
) |
1 |
|
3 |
|
||||
Changes in unrealized gains (losses) on available-for-sale securities, net of taxes |
|
(25 |
) |
(30 |
) |
129 |
|
115 |
|
||||
Other comprehensive income, net of tax |
|
28,005 |
|
4,222 |
|
31,344 |
|
11,224 |
|
||||
Comprehensive income |
|
$ |
34,130 |
|
$ |
11,504 |
|
$ |
42,198 |
|
$ |
29,264 |
|
The following summarizes activity in accumulated other comprehensive income (loss) related to derivatives, net of income taxes, held by us (in thousands):
|
|
|
|
|
Balance, October 1, 2006 |
|
$ |
(135 |
) |
Changes in fair value of derivatives |
|
|
|
|
Net losses reclassified from OCI |
|
3 |
|
|
Balance, March 31, 2007 |
|
$ |
(132 |
) |
|
|
|
|
|
Balance, September 30, 2007 |
|
$ |
(98 |
) |
Changes in fair value of derivatives |
|
|
|
|
Net losses reclassified from OCI |
|
3 |
|
|
Balance, March 29, 2008 |
|
$ |
(95 |
) |
Accumulated other comprehensive income (net of tax) at March 29, 2008 is comprised of accumulated translation adjustments of $102.1 million and net loss on derivative instruments of $0.1 million. Accumulated other comprehensive income (net of tax) at September 29, 2007 is comprised of accumulated translation adjustments of $71.0 million, net loss on derivative instruments of $0.1 million and unrealized loss on available-for-sale securities of $0.2 million, respectively.
10. EARNINGS PER SHARE
Basic earnings per share is computed based on the weighted average number of shares outstanding during the period, excluding unvested restricted stock. Diluted earnings per share is computed based on the weighted average number of shares
15
outstanding during the period increased by the effect of dilutive employee stock awards, including stock options, restricted stock and stock purchase contracts, using the treasury stock method.
The following table presents information necessary to calculate basic and diluted earnings per share (in thousands, except per share data):
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
||||
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
||||
Weighted average shares outstanding (1)basic |
|
31,394 |
|
31,417 |
|
31,406 |
|
31,378 |
|
||||
Dilutive effect of employee stock plans |
|
480 |
|
520 |
|
510 |
|
652 |
|
||||
Weighted average shares |
|
31,874 |
|
31,937 |
|
31,916 |
|
32,030 |
|
||||
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
6,125 |
|
$ |
7,282 |
|
$ |
10,854 |
|
$ |
18,040 |
|
|
|
|
|
|
|
|
|
|
|
||||
Net income per basic share |
|
$ |
0.20 |
|
$ |
0.23 |
|
$ |
0.35 |
|
$ |
0.57 |
|
Net income per diluted share |
|
$ |
0.19 |
|
$ |
0.23 |
|
$ |
0.34 |
|
$ |
0.56 |
|
(1) Net of restricted stock
A total of 2,348,968 and 2,141,206 potentially dilutive securities have been excluded from the dilutive share calculation for the second quarter of fiscal 2008 and fiscal 2007, respectively, as their effect was anti-dilutive. A total of 2,430,969 and 1,535,628 potentially dilutive securities have been excluded from the dilutive share calculation for the six months ended March 29, 2008 and March 31, 2007, respectively, as their effect was anti-dilutive.
In September 2004, the Emerging Issues Task Force (EITF) reached final consensus on EITF No. 04-8, The Effect of Contingently Convertible Instruments on Diluted Earnings per Share, that contingently convertible debt should be treated as convertible debt and included in the calculation of diluted EPS. The assumed proceeds under the treasury stock method were calculated by subtracting the aggregate weighted-average conversion price from the average market price of the shares related to the contingently convertible debt. As the market price for our shares did not reach the conversion price at any point during the three and six months ended March 31, 2007, there was no dilutive effect from our $200.0 million 2.75% convertible subordinated notes in our diluted EPS calculation under the treasury stock method. Therefore we did not include any shares related to the convertible subordinated notes, in accordance with the provisions of EITF No. 90-19, Convertible Bonds With Issuer Option to Settle in Cash Upon Conversion and SFAS No. 128, Earnings Per Share.
As the contingently convertible debt was paid off on August 21, 2007, there is no impact from EITF No. 04-8 in the three and six months ended March 29, 2008.
11. STOCK REPURCHASE
On February 12, 2008, the Company announced that the Board of Directors had authorized the Company to repurchase up to $225 million of its common stock through a modified Dutch Auction tender offer and an additional $25 million of its common stock, following the completion or termination of the tender offer, under its stock repurchase program, terminating no later than February 11, 2009. On March 17, 2008, we completed our tender offer, repurchased and retired 7,972,313 shares of outstanding common stock at a price of $28.50 per share for a total of $228.1 million, including expenses. Such repurchases were accounted for as a reduction in additional paid in capital. Upon completion of the offer, we had 23,628,161 shares of common stock outstanding.
12. INCOME TAXES
The Company accounts for income taxes under the provisions of SFAS No. 109, Accounting for Income Taxes (SFAS 109). Under the provisions of SFAS 109, deferred tax assets and liabilities are recognized based on the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, utilizing
16
the currently enacted tax rates that are expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
Income tax expense includes a provision for federal, state and foreign taxes based on the annual estimated effective tax rate applicable to the Company and its subsidiaries. The Companys estimated effective tax rate for the three months and six months ended March 29, 2008 was 50.4% and 44.0%, respectively. The difference between the statutory rate of 35% and the Companys effective tax rate for the three months ended March 29, 2008 was due primarily to permanent differences related to foreign currency exchange gains on previously taxed income distributions from foreign subsidiaries and deemed dividend inclusions under the Subpart F tax rules, partially offset by the benefit of foreign tax credits. The difference between the statutory rate of 35% and the Companys effective tax rate for the six months ended March 29, 2008 was due primarily to permanent differences related to foreign currency exchange gains on previously taxed income distributions from foreign subsidiaries and deemed dividend inclusions under the Subpart F tax rules, partially offset by the benefit of foreign tax credits and research and development tax credits.
Determining the consolidated provision for income tax expense, income tax liabilities and deferred tax assets and liabilities involves judgment. The Company calculates and provides for income taxes in each of the tax jurisdictions in which it operates, which involves estimating current tax exposures as well as making judgments regarding the recoverability of deferred tax assets in each jurisdiction. The estimates used could differ from actual results, which may have a significant impact on operating results in future periods.
Effective September 30, 2007, the Company adopted the provisions of FIN 48 and FSP FIN 48-1. Upon adoption, the Company recorded a cumulative effect of a change in accounting principle that resulted in a decrease to retained earnings of $1.4 million in accordance with the transition rules under FIN 48. The Company had historically classified interest and penalties and unrecognized tax benefits as current liabilities. With the adoption of FIN 48, the Company classifies gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as non-current liabilities in the condensed consolidated balance sheets. The total amount of gross unrecognized tax benefits as of the date of adoption of FIN 48 was $44.9 million, of which $21.7 million, if recognized, would affect the Companys effective tax rate. As of March 29, 2008, the total amount of gross unrecognized tax benefits was $45.7 million, of which $22.3 million, if recognized, would affect the Companys effective tax rate. The Companys total gross unrecognized tax benefit was classified as non-current liabilities in the condensed consolidated balance sheets.
The Companys policy to include interest and penalties related to unrecognized tax benefits within the provision for income taxes did not change as a result of adopting FIN 48. As of the date of adoption, the Company had accrued $4.7 million for the gross interest and penalties relating to the gross unrecognized tax benefits. As of March 29, 2008, the total amount of gross interest and penalties accrued was $5.6 million, which is classified as non-current liabilities in the condensed consolidated balance sheets.
The Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and in many state and foreign jurisdictions. For U.S. federal income tax purposes, all years prior to 1999 are closed. The years 2003 and 2004 are currently under examination by the IRS. The IRS has also indicated that it may consider an audit of our 2005 and 2006 tax returns. In major state jurisdictions and major foreign jurisdictions, the years subsequent to 1998 generally remain open and could be subject to examination by the taxing authorities.
Management believes that it has adequately provided for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. Should any issues addressed in the Companys tax audits be resolved in a manner not consistent with managements expectations, the Company could be required to adjust its provision for income tax in the period such resolution occurs. Although timing of the resolution and/or closure of audits is highly uncertain, the Company does not believe it is reasonably possible that its unrecognized tax benefits would materially change in the next 12 months.
13. SEGMENT INFORMATION
During the second quarter of fiscal 2007, we established a new organizational and reporting structure whereby our previously single reportable operating segment was separated into two operating segments: Commercial Lasers and Components (CLC) and Specialty Lasers and Systems (SLS). CLC focuses on higher volume products that are offered in set configurations. The product architectures are designed for easy exchange at the point of use such that product service and repairs are based upon advanced replacement and depot (i.e., factory) repair. CLCs primary markets include OEM components and instrumentation and materials processing. SLS develops and manufacturers configurable, advanced-performance products largely serving the microelectronics and scientific research markets. The size and
17
complexity of many of the SLS products require service to be performed at the customer site by factory-trained field service engineers.
We have identified CLC and SLS as operating segments for which discrete financial information was available. Both operating segments have engineering, marketing, product business management and product line management. Prior period financial information has been restated to conform to the current segment presentation. A small portion of our outside revenue is attributable to projects and recently developed products for which a segment has not yet been determined. The associated direct and indirect costs are presented in the category of Corporate and other, along with other corporate costs as described below.
Pursuant to SFAS 131, Disclosures about Segments of an Enterprise and Related Information, our Chief Executive Officer has been identified as the chief operating decision maker (CODM) as he assesses the performance of the segments and decides how to allocate resources to the segments. Income (loss) from operations is the measure of profit and loss that our CODM uses to assess performance and make decisions. Assets are not a measure used to assess the performance of the company by the CODM; therefore we do not report assets by segment internally or in our disclosures. Income (loss) from operations represents the net sales less the cost of sales and direct operating expenses incurred within the operating segments as well as allocated expenses such as shared sales and manufacturing costs. We do not allocate to our operating segments certain operating expenses, which we manage separately at the corporate level. These unallocated costs include stock-based compensation, corporate functions (certain research and development, management, finance, legal and human resources) and are included in the results below under Corporate and other in the reconciliation of operating results. Management does not consider unallocated Corporate and other costs in its measurement of segment performance.
The following table provides net sales and income from operations for our operating segments (in thousands):
|
|
Three Months Ended |
|
Six Months Ended |
|
||||||||
|
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
||||
|
|
2008 |
|
2007 |
|
2008 |
|
2007 |
|
||||
Net sales: |
|
|
|
|
|
|
|
|
|
||||
Commercial Lasers and Components |
|
$ |
75,962 |
|
$ |
69,720 |
|
$ |
144,566 |
|
$ |
136,947 |
|
Specialty Laser Systems |
|
79,955 |
|
82,316 |
|
155,622 |
|
161,086 |
|
||||
Corporate and other |
|
25 |
|
80 |
|
50 |
|
1,592 |
|
||||
Total net sales |
|
$ |
155,942 |
|
$ |
152,116 |
|
$ |
300,238 |
|
$ |
299,625 |
|
|
|
|
|
|
|
|
|
|
|
||||
Income from operations: |
|
|
|
|
|
|
|
|
|
||||
Commercial Lasers and Components |
|
$ |
9,252 |
|
$ |
7,096 |
|
$ |
14,799 |
|
$ |
15,865 |
|
Specialty Laser Systems |
|
10,362 |
|
14,020 |
|
19,539 |
|
24,901 |
|
||||
Corporate and other |
|
(11,531 |
) |
(14,730 |
) |
(25,104 |
) |
(26,292 |
) |
||||
Total income from operations |
|
$ |
8,083 |
|
$ |
6,386 |
|
$ |
9,234 |
|
$ |
14,474 |
|
14. SUBSEQUENT EVENTS
Effective March 31, 2008, we entered into a $40 million unsecured revolving credit account with Union Bank of California, which expires on March 31, 2010. Our Union Bank of California agreement is subject to covenants related to financial ratios and tangible net worth.
In April 2008, we initiated a tender offer related to certain discount options discovered during our voluntary review of our historical stock option practices. Discount options are options with an exercise price that is less than the fair market value of the shares underlying the option at the time of grant. The discounted options included in this offer are certain options which vested after December 31, 2004. During the tender offer period, employees have, among other things, the ability to amend the exercise price per share for eligible options to the fair market value of the underlying option as of the measurement date of that option, and receive a cash payment for the difference between the discounted share price and the amended share price. This amendment is designed to allow holders of discount options to avoid certain adverse tax consequences associated with discount options. The offer expires on May 9, 2008.
On April 16, 2008, we announced that we entered into an agreement to sell certain assets of our Auburn Optics manufacturing operation to Research Electro-Optics, Inc. (REO), a privately held optics manufacturing and technology
18
company. We also entered into a strategic supply agreement with REO. REO will provide optical manufacturing capabilities for us, including fabrication and coating of optical components. The transition of the optics manufacturing assets from Auburn to REO will begin immediately and is expected to be completed no later than the end of the second quarter of fiscal 2009.
In April 2008, we finalized our lease agreement and began to move employees into an additional building in Santa Clara, California. The future minimum lease payments total $12.2 million over seven years.
Item 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
COMPANY OVERVIEW
BUSINESS BACKGROUND
We are one of the worlds leading suppliers of photonics-based solutions in a broad range of commercial and scientific research applications. We design, manufacture and market lasers, precision optics and related accessories for a diverse group of customers. Since inception in 1966, we have grown through internal expansion and through strategic acquisitions of complementary businesses, technologies, intellectual property, manufacturing processes and product offerings.
During the second quarter of fiscal 2007, we established a new organizational and reporting structure whereby our previously single reportable operating segment was separated into two operating segments: Commercial Lasers and Components (CLC) and Specialty Lasers and Systems (SLS). The new segmentation reflects the go-to-market strategies for various products and markets. While both segments work to deliver cost-effective photonics solutions, CLC focuses on higher volume products that are offered in set configurations. The product architectures are designed for easy exchange at the point of use such that substantially all product service and repairs are based upon advanced replacement and depot (i.e., factory) repair. CLCs primary markets include OEM components and instrumentation and materials processing. SLS develops and manufactures configurable, advanced-performance products largely serving the microelectronics and scientific research markets. The size and complexity of many of the SLS products require service to be performed at the customer site by factory-trained field service engineers.
Income (loss) from operations is the measure of profit and loss that our chief operating decision maker (CODM) uses to assess performance and make decisions. Income (loss) from operations represents the net sales less the cost of sales and direct operating expenses incurred within the operating segments as well as allocated expenses such as shared sales and manufacturing costs. We do not allocate to our operating segments certain operating expenses, which we manage separately at the corporate level. These unallocated costs include stock-based compensation, corporate functions (certain research and development, management, finance, legal and human resources) and are included in Corporate and Other. Management does not consider unallocated Corporate and Other costs in its measurement of segment performance.
MARKET APPLICATIONS
Our products address a broad range of applications that we group into the following markets: Microelectronics, Materials Processing, OEM Components and Instrumentation, and Scientific Research and Government Programs. Effective the first quarter of fiscal 2008, we combined the former Graphic Arts and Display market applications for bookings and revenues into the OEM Components and Instrumentation market applications. Prior period market application information for bookings and revenues reflects this combination.
OUR STRATEGY
We strive to develop innovative and proprietary products and solutions that meet the needs of our customers and that are based on our core expertise in lasers and optical technologies. In pursuit of our strategy, we intend to:
· Leverage our technology portfolio and application engineering to lead the proliferation of photonics into broader marketsWe will continue to identify opportunities in which our technology portfolio and application engineering can be used to offer innovative solutions and gain access to new markets.
19
· Optimize our leadership position in existing marketsThere are a number of markets where we have historically been at the forefront of technological development and product deployment and from which we have derived a substantial portion of our revenues. We plan to optimize our financial returns from these markets.
· Maintain and develop additional strong collaborative customer and industry relationshipsWe believe that the Coherent brand name and reputation for product quality, technical performance and customer satisfaction will help us to further develop our loyal customer base. We plan to maintain our current customer relationships and develop new ones with customers who are industry leaders and work together with these customers to design and develop innovative product systems and solutions as they develop new technologies.
· Develop and acquire new technologies and market shareWe will continue to enhance our market position through our existing technologies and develop new technologies through our internal research and development efforts, as well as through the acquisition of additional complementary technologies, intellectual property, manufacturing processes and product offerings.
· Focus on long-term improvement of adjusted EBITDA expressed as a percentage of net salesWe define adjusted EBITDA as earnings before interest, taxes, depreciation, amortization, stock compensation expenses and certain other non-operating income and expense items.
APPLICATION OF CRITICAL ACCOUNTING POLICIES
Our discussion and analysis of financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America and pursuant to the rules and regulations of the SEC. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, accounting for long-lived assets (including goodwill and intangible assets), inventory valuation, warranty reserves, stock-based compensation and accounting for income taxes.
Revenue Recognition
We recognize revenue when all four revenue recognition criteria have been met: persuasive evidence of an arrangement exists, the product has been delivered or the service has been rendered, the price is fixed or determinable and collection is probable. Revenue from product sales is recorded when all of the foregoing conditions are met and risk of loss and title passes to the customer. Our products typically include a one-year warranty and the estimated cost of product warranty claims (based on historical experience) is recorded at the time the sale is recognized. Sales to customers are generally not subject to any price protection or return rights.
The vast majority of our sales are made to original equipment manufacturers (OEMs), distributors, resellers and end-users in the non-scientific market. Sales made to these customers do not require installation of the products by us and are not subject to other post-delivery obligations, except in occasional instances where we have agreed to perform installation or provide training. In those instances, we defer revenue related to installation services or training until these services have been rendered. We allocate revenue from multiple element arrangements to the various elements based upon relative fair values, which are determined based on the price charged for each deliverable on a standalone basis.
Should changes in conditions cause management to determine these criteria are not met for certain future transactions, revenue recognized for any reporting period could be adversely affected. Failure to obtain anticipated orders due to delays or cancellations of orders could have a material adverse effect on our revenue. In addition, pressures from customers to reduce our prices or to modify our existing sales terms may have a material adverse effect on our revenue in future periods.
Our sales to distributors, resellers and end-user customers typically do not have customer acceptance provisions and only certain of our sales to OEM customers have customer acceptance provisions. Customer acceptance is generally limited to performance under our published product specifications. For the few product sales that have customer acceptance provisions because of higher than published specifications, (1) the products are tested and accepted by the customer at our site or by the customers acceptance of the results of our testing program prior to shipment to the customer, or (2) the revenue is deferred until customer acceptance occurs.
20
Sales to end-users in the scientific market typically require installation and, thus, involve post-delivery obligations; however our post-delivery installation obligations are not essential to the functionality of our products. We defer revenue related to installation services until completion of these services.
For most products, training is not provided; therefore, no post-delivery training obligation exists. However, when training is provided to our customers, it is typically priced separately and recognized as revenue after these services have been provided.
Long-Lived Assets
We evaluate long-lived assets whenever events or changes in business circumstances or our planned use of assets indicate that their carrying amounts may not be fully recoverable or that their useful lives are no longer appropriate. Reviews are performed to determine whether the carrying values of assets are impaired based on comparison to either the discounted expected future cash flows (in the case of goodwill) or to the undiscounted expected future cash flows (for all other long-lived assets). If the comparison indicates that impairment exists, the impaired asset is written down to its fair value. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected discounted and undiscounted cash flows.
At March 29, 2008, we had $120.5 million of goodwill and purchased intangible assets on our consolidated balance sheet. At March 29, 2008, we had $107.5 million of property and equipment on our consolidated balance sheet. The Company reviewed impairment indicators during the second quarter of fiscal 2008 and determined that no impairment was indicated.
It is reasonably possible that the estimates of anticipated future net revenue, the remaining estimated economic life of the products and technologies, or both, could differ from those used to assess the recoverability of these assets. In that event, additional impairment charges or shortened useful lives of certain long-lived assets may be required.
Inventory Valuation
We record our inventory at the lower of cost (computed on a first-in, first-out basis) or market. We write-down our inventory to its estimated market value based on assumptions about future demand and market conditions. Inventory write-downs are generally recorded within guidelines set by management when the inventory for a device exceeds 12 months of its demand and when individual parts have been in inventory for greater than 12 months. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required which could materially affect our future results of operations. Due to rapidly changing forecasts and orders, additional write-downs for excess or obsolete inventory, while not currently expected, could be required in the future. In the event that alternative future uses of fully written down inventories are identified, we may experience better than normal profit margins when such inventory is sold. Differences between actual results and previous estimates of excess and obsolete inventory could materially affect our future results of operations. We write-down our demo inventory by amortizing the cost of demo inventory over a twenty month period starting from the fourth month after such inventory is placed in service.
Warranty Reserves
We provide warranties on certain of our product sales (generally one year) and allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires us to make estimates of product return rates and expected costs to repair or replace the products under warranty. We currently establish warranty reserves based on historical warranty costs for each product line. If actual return rates and/or repair and replacement costs differ significantly from our estimates, adjustments to cost of sales may be required in future periods.
Stock-Based Compensation
In accordance with the fair value recognition provisions of SFAS No. 123 (Revised 2004), Share-Based Payment, (SFAS 123(R)), we recognize compensation expense for all share-based payment awards on a straight-line basis over the respective requisite service period of the awards. Stock-based compensation expense is determined based on the fair value of the awards on the date of grant.
SFAS 123(R) requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of
21
highly subjective assumptions, including the options expected life and the expected price volatility of the underlying stock. The expected stock price volatility assumption was determined using our historical volatility.
Income Taxes
As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets.
We record a valuation allowance to reduce our deferred tax assets to an amount that more likely than not will be realized. While we have considered future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance, in the event we were to determine that we would be able to realize our deferred tax assets in the future in excess of our net recorded amount, an adjustment to the allowance for the deferred tax assets would increase income in the period such determination was made. Likewise, should we determine that we would not be able to realize all or part of our net deferred tax assets in the future, an adjustment to the valuation allowance for the deferred tax assets would be charged to income in the period such determination was made.
Effective September 30, 2007, the Company adopted the provisions of FIN 48, which creates a single model to address accounting for uncertainty in tax positions by prescribing a minimum recognition threshold that a tax position is required to meet before being recognized in the financial statements. FIN 48 establishes a two-step approach for evaluating tax positions. The first step, recognition, occurs when a company concludes (based solely on the technical aspects of the matter) that a tax position is more likely than not to be sustained upon examination by a taxing authority. The second step, measurement, is only considered after step one has been satisfied and measures any tax benefit at the largest amount that is deemed more likely than not to be realized upon ultimate settlement of the uncertainty. These determinations involve significant judgment by management. Tax positions that fail to qualify for initial recognition are recognized in the first subsequent interim period that they meet the more likely than not standard, when they are resolved through negotiation or litigation with factual interpretation, judgment and certainty. Tax laws and regulations themselves are complex and are subject to change as a result of changes in fiscal policy, changes in legislation, evolution of regulations and court filings. Therefore, the actual liability for U.S. or foreign taxes may be materially different from our estimates, which could result in the need to record additional tax liabilities or potentially to reverse previously recorded tax liabilities.
KEY PERFORMANCE INDICATORS
The following is a summary of some of the quantitative performance indicators (as defined below) that may be used to assess our results of operations and financial condition:
|
|
Three Months Ended |
|
|
|
|
|
|||||
|
|
March 29, |
|
March 31, |
|
|
|
|
|
|||
|
|
2008 |
|
2007 |
|
Change |
|
% Change |
|
|||
|
|
(Dollars in thousands) |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||
Bookings |
|
$ |
148,578 |
|
$ |
151,865 |
|
$ |
(3,287 |
) |
(2.2 |
)% |
Net salesCLC |
|
$ |
75,962 |
|
$ |
69,720 |
|
$ |
6,242 |
|
9.0 |
% |
Net salesSLS |
|
$ |
79,955 |
|
$ |
82,316 |
|
$ |
(2,361 |
) |
(2.9 |
)% |
Gross profit as a percentage of net salesCLC |
|
45.6 |
% |
42.8 |
% |
2.8 |
% |
6.6 |
% |
|||
Gross profit as a percentage of net salesSLS |
|
41.7 |
% |
42.9 |
% |
(1.2 |
)% |
(3.0 |
)% |
|||
Research and development as a percentage of net sales |
|
12.5 |
% |
12.4 |
% |
0.1 |
% |
0.4 |
% |
|||
Income before income taxes |
|
$ |
12,346 |
|
$ |
11,482 |
|
$ |
864 |
|
7.5 |
% |
Cash provided by operating activities |
|
$ |
15,564 |
|
$ |
11,202 |
|
$ |
4,362 |
|
38.9 |
% |
Days sales outstanding in receivables |
|
65.0 |
|
63.5 |
|
1.5 |
|
2.5 |
% |
|||
Days sales outstanding in inventories |
|
67.3 |
|
61.2 |
|
6.1 |
|
10.0 |
% |
|||
Capital spending as a percentage of net sales |
|
2.9 |
% |
4.9 |
% |
(2.0 |
)% |
(41.0 |
)% |
|
|
Six Months Ended |
|
|
|
|
|
|||||
|
|
March 29, |
|
March 31, |
|
|
|
|
|
|||
|
|
2008 |
|
2007 |
|
Change |
|
% Change |
|
|||
|
|
(Dollars in thousands) |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|||
Bookings |
|
$ |
303,435 |
|
$ |
288,073 |
|
$ |
15,362 |
|
5.3 |
% |
Net salesCLC |
|
$ |
144,566 |
|
$ |
136,947 |
|
$ |
7,619 |
|
5.6 |
% |
Net salesSLS |
|
$ |
155,622 |
|
$ |
161,086 |
|
$ |
(5,464 |
) |
(3.4 |
)% |
Gross profit as a percentage of net salesCLC |
|
44.0 |
% |
44.1 |
% |
(0.1 |
)% |
(0.2 |
)% |
|||
Gross profit as a percentage of net salesSLS |
|
42.0 |
% |
41.1 |
% |
0.9 |
% |
2.0 |
% |
|||
Research and development as a percentage of net sales |
|
12.6 |
% |
12.4 |
% |
0.2 |
% |
1.2 |
% |
|||
Income before income taxes |
|
$ |
19,378 |
|
$ |
24,844 |
|
$ |
(5,466 |
) |
(22.0 |
)% |
Cash provided by operating activities |
|
$ |
28,641 |
|
$ |
39,936 |
|
$ |
(11,295 |
) |
(28.3 |
)% |
Capital spending as a percentage of net sales |
|
3.1 |
% |
4.2 |
% |
(1.1 |
)% |
(26.6 |
)% |
22
Definitions and analysis of these performance indicators are as follows:
Bookings
Bookings represent orders expected to be shipped within 12 months and services to be provided pursuant to service contracts. While we generally have not experienced a significant rate of cancellation, bookings are generally cancelable by our customers without substantial penalty and, therefore, we can not assure all bookings will be converted to net sales.
Second quarter bookings decreased 2.2% and bookings for the six months ended March 29, 2008 increased 5.3% from the same periods one year ago. For both the quarter and six months, increases in the microelectronics and scientific and government programs markets were partially offset by decreases in the OEM components and instrumentation and materials processing markets.
Microelectronics
Orders from semiconductor capital equipment applications remained soft due to the downturn in the industry. While we continue to focus on market share gains, we do not expect any appreciable impact before the end of the calendar year. Demand for lasers used in via drilling was strong, due both from cell phone manufacturing and IC substrate packaging. As these markets are strongly influenced by consumer spending, we are closely tracking macroeconomic indicators. Bookings from laser direct imaging decreased, which is reflective of current market conditions. The long-term key to this market is the dollars per Watt and we are aggressively pursuing new product architectures to support this goal.
For the past few quarters, flat panel display manufacturers have made process improvements to increase annealing yields. With capacity absorption maximized, we have received orders for additional laser systems. These will be used for sequential lateral solidification (SLS) processing of thin-film transistors and active matrix organic light-emitting diode (AMOLED) panels and be equipped with an excimer light source and our line-beam delivery optics.
The solar cell market has been receiving attention in the press, especially with oil at record highs. We have seen a steady increase in solar applications during each of the last two fiscal years. Solar bookings increased in the second quarter of fiscal 2008 and the total for the first six months of fiscal 2008 has almost matched the whole of fiscal 2007. Given the industry trend, this growth is likely to be sustained throughout this fiscal year and beyond. It is also noteworthy that we are providing ultraviolet, visible and infrared light sources to this market for a variety of applications in thin-film and crystalline silicon processing.
At the Japan Laser Expo in Yokohama in April 2008, we formally launched the Talisker laser system. It is the first in a series of lasers based upon an ultrafast fiber oscillator that has been designed and built to Telecordia standards. In the Talisker, the ultrafast oscillator is paired with a high power amplifier to produce energetic, short pulses of light resulting in high peak power output. Customer tests have demonstrated several important results including negligible heat affected zones (HAZ) and the ability to eliminate certain post-machining processes, such as post-scribe plasma processing in the case of silicon scribing. Customer interest in Talisker is strong for a wide variety of microelectronics applications including solar cell manufacturing and precision glass scribing for the latest hand-held devices. By applying subsystems from other products within our portfolio, the Talisker is the only laser of its type available in infrared, visible and ultraviolet configurations. Customers have already begun to place orders and revenue shipments will commence in the third quarter of fiscal 2008.
Scientific and Government Programs
While our market share and order stream for Chameleon remains solid, the second quarter of fiscal 2008 was marked by a surge in demand for high-performance amplifiers. This was due in part to product enhancements, which addressed customer
23
needs, as well as the release of government funding. At Photonics West in January 2008, we introduced the Mantis, an ultrafast laser system that incorporates a high-power OPS pump laser. The order rate for the Mantis is meeting our expectations and product has begun to ship.
OEM Components and Instrumentation
Effective in the first quarter of fiscal 2008, we have incorporated the former graphic arts and display market into OEM components and instrumentation market. Orders from instrumentation applications increased slightly from the first quarter of fiscal 2008, but decreased from the record-setting second quarter of fiscal 2007. Orders from medical OEMs decreased following an all-time high set in the first quarter of fiscal 2008. Nonetheless, the market remains very active. We received strong bookings from refractive surgery customers due in part to ongoing product portfolio consolidation. In the photocoagulation market, we have secured another major account for the OPSL 577. We look forward to having all these accounts receive FDA approval. We have also noted a renewed interest in CO2-based skin resurfacing, which has resulted in meaningful unit volume for our GEM Series lasers, whose performance characteristics provide a favorable overall patient experience.
Materials Processing
The materials processing market is in a very dynamic state. Consumer sentiment in the U.S. has impacted imports, causing orders for new production equipment to weaken. We have seen evidence of this in China. However, demand from the Chinese domestic and European markets has remained strong, partially offsetting the softness in the U.S. Given the regional interdependencies and unclear outlook, we expect customers to adopt a more conservative posture, especially on inventory.
Marking and engraving applications continue to be our prime targets. Specialty marking of glass, diamonds and identification cards applications were strong. On the product front, our recently released E-Series CO2 platform is performing well. The integrated design and cost of ownership model have been well received by the customer base. We are receiving first-time and repeat orders for this product. We are also seeing increasing demand for our Matrix Series laser platform.
Net Sales
Net sales include sales of lasers, precision optics, related accessories and service contracts. Net sales for the second fiscal quarter increased 9.0% in our CLC segment and decreased 2.9% in our SLS segment from the same quarter one year ago. Net sales for the first six months of fiscal 2008 increased 5.6% in our CLC segment and decreased 3.4% in our SLS segment from the same period one year ago. For a description of the reasons for changes in net sales refer to the Results of Operations section of this quarterly report.
Gross Profit as a Percentage of Net Sales
Gross profit as a percentage of net sales (gross profit percentage) is calculated as gross profit for the period divided by net sales for the period. Gross profit percentage in the second quarter increased from 42.8% to 45.6% in our CLC segment and decreased from 42.9% to 41.7% in our SLS segment from the same quarter one year ago. Gross profit percentage for the first six months of fiscal 2008 decreased from 44.1% to 44.0% in our CLC segment and increased from 41.1% to 42.0% in our SLS segment from the same period one year ago. For a description of the reasons for changes in gross profit refer to the Results of Operations section of this quarterly report.
Research and Development as a Percentage of Net Sales
Research and development as a percentage of net sales (R&D percentage) is calculated as research and development expense for the period divided by net sales for the period. Management considers R&D percentage to be an important indicator in managing our business as investing in new technologies is a key to future growth. R&D percentage increased to 12.5% from 12.4% in the second fiscal quarter and increased to 12.6% from 12.4% for the first six months of fiscal 2008 compared to the same periods one year ago. For a more complete description of the reasons for changes in R&D percentage refer to the Results of Operations section of this quarterly report.
Net Cash Provided by Operating Activities
Net cash provided by operating activities shown on our Condensed Consolidated Statements of Cash Flows primarily represents the excess of cash collected from billings to our customers and other receipts over cash paid to our vendors for
24
expenses and inventory purchases to run our business. This amount represents cash generated by current operations to pay for equipment, technology, and other investing activities, to repay debt, fund acquisitions, repurchase our common stock and for other financing purposes. We believe this is an important performance indicator because cash generation over the long term is essential to maintaining a healthy business and providing funds to help fuel growth. We believe generating positive cash from operations is an indication that our products are achieving a high level of customer satisfaction and that we are appropriately monitoring our expenses, inventory levels and cash collection efforts. For a more complete description of the reasons for changes in Net Cash Provided by Operating Activities refer to the Liquidity and Capital Resources section of this quarterly report.
Days Sales Outstanding in Receivables
We calculate days sales outstanding (DSO) in receivables as net receivables at the end of the period divided by net sales during the period and then multiplied by the number of days in the period, using 90 days for quarters. DSO in receivables indicates how well we are managing our collection of receivables, with lower DSO in receivables resulting in more cash flow available. The more money we have tied up in receivables, the less money we have available for research and development, acquisitions, expansion, marketing and other activities to grow our business. Our DSO in receivables for the second quarter of fiscal 2008 increased 1.5 days from the same quarter one year ago due primarily to the impact of foreign exchange rates and higher sales volumes in Asia, partially offset by a lower concentration of sales later in the quarter.
Days Sales Outstanding in Inventories
We calculate DSO in inventories as net inventories at the end of the period divided by net sales of the period and then multiplied by the number of days in the period, using 90 days for quarters. DSO in inventories indicates how well we are managing our inventory levels, with lower DSO in inventories resulting in more cash flow available. The more money we have tied up in inventory, the less money we have available for research and development, acquisitions, expansion, marketing and other activities to grow our business. Our DSO in inventories for the second quarter of fiscal 2008 increased 6.1 days from the same quarter one year ago primarily due to increased inventory levels for customer support, in preparation for new product launches and to support higher sales volumes as well as the impact of foreign exchange rates.
Capital Spending as a Percentage of Net Sales
Capital spending as a percentage of net sales (capital spending percentage) is calculated as capital expenditures for the period divided by net sales for the period. Capital spending percentage indicates the extent to which we are expanding or improving our operations, including investments in technology. Management monitors capital spending levels as this assists management in measuring our cash flows, net of capital expenditures. Our capital spending percentage decreased to 2.9% and 3.1% for the second quarter and six months from 4.9% and 4.2%, respectively, for the same periods one year ago. We anticipate that capital spending for fiscal 2008 will be approximately 4% of net sales.
SIGNIFICANT EVENTS
On December 18, 2007, we announced that the Securities and Exchange Commission (SEC) notified us that it had denied our motion to stay the decision of the NASDAQ Stock Market LLC (Nasdaq), to suspend and delist our common stock. Therefore, effective at the opening of business on Wednesday, December 19, 2007, our common stock was suspended from trading on the Nasdaq Global Select Market, and was subsequently delisted. Following our delisting from the Nasdaq Global Select Market, we began trading on the Pink Sheet Electronic Quotation Service. Our shares of common stock were re-listed on the NASDAQ Global Select Market with the opening of trading on Thursday, February 14, 2008.
On February 12, 2008, the Company announced that the Board of Directors had authorized the Company to repurchase up to $225 million of its common stock through a modified Dutch Auction tender offer and an additional $25 million of its common stock, following the completion or termination of the tender offer, under its stock repurchase program, terminating no later than February 11, 2009. On March 17, 2008, we completed our tender offer, repurchased and retired 7,972,313 shares of outstanding common stock at a price of $28.50 per share for a total of $228.1 million, including expenses. Such repurchases were accounted for as a reduction in additional paid in capital. Upon completion of the offer, we had 23,628,161 shares of common stock outstanding.
25
RESULTS OF OPERATIONS
CONSOLIDATED SUMMARY
The following table sets forth, for the periods indicated, the percentage of total net sales represented by the line items reflected in our condensed consolidated statements of operations:
|
|
Three Months Ended |
|
Six Months Ended |
|
||||
|
|
March 29, |
|
March 31, |
|
March 29, |
|
March 31, |
|
Net sales |
|
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
Cost of sales |
|
57.0 |
% |
57.6 |
% |
57.5 |
% |
57.8 |
% |
Gross profit |
|
43.0 |
% |
42.4 |
% |
42.5 |
% |
42.2 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
|
Research and development |
|
12.5 |
% |
12.4 |
% |
12.6 |
% |
12.4 |
% |
Selling, general and administrative |
|
24.0 |
% |
24.4 |
% |
25.3 |
% |
23.6 |
% |
Restructuring and other charges |
|
|
% |
0.1 |
% |
|
% |
0.1 |
% |
Amortization of intangible assets |
|
1.4 |
% |
1.3 |
% |
1.5 |
% |
1.3 |
% |
Total operating expenses |
|
37.9 |
% |
38.2 |
% |
39.4 |
% |
37.4 |
% |
Income from operations |
|
5.1 |
% |
4.2 |
% |
3.1 |
% |
4.8 |
% |
Other income (expense): |
|
|
|
|
|
|
|
|
|
Interest and dividend income |
|
2.2 |
% |
4.1 |
% |
2.5 |
% |
4.1 |
% |
Interest expense |
|
(0.1 |
)% |
(1.3 |
)% |
(0.1 |
)% |
(1.2 |
)% |
Othernet |
|
0.7 |
% |
0.5 |
% |
1.0 |
% |
0.6 |
% |
Total other income, net |
|
2.8 |
% |
3.3 |
% |
3.4 |
% |
3.5 |
% |
Income before income taxes |
|
7.9 |
% |
7.5 |
% |
6.5 |
% |
8.3 |
% |
Provision for income taxes |
|
4.0 |
% |
2.7 |
% |
2.9 |
% |
2.3 |
% |
Net income |
|
3.9 |
% |
4.8 |
% |
3.6 |
% |
6.0 |
% |
Net income for the second quarter of fiscal 2008 was $6.1 million ($0.19 per diluted share) including a $1.4 million tax expense in connection with an internal dividend from one of our European subsidiaries, $1.5 million of after-tax costs related to our restatement of financial statements and litigation resulting from our internal stock option investigation and $3.7 million of after-tax stock-related compensation expense. Net income for the second quarter of fiscal 2007 was $7.3 million ($0.23 per diluted share) including $2.5 million of after-tax costs related to our internal stock option investigation and litigation and $2.6 million of after-tax stock-related compensation expense. Net income for the first six months of fiscal 2008 was $10.9 million ($0.34 per diluted share) including $4.4 million of after-tax costs related to our restatement of financial statements and litigation resulting from our internal stock option investigation, $5.7 million of after-tax stock-related compensation expense and a $1.4 million tax expense in connection with an internal dividend from one of our European subsidiaries. Net income for the first six months of fiscal 2007 was $18.0 million ($0.56 per diluted share) including $3.6 million of after-tax costs related to our internal stock option investigation. Results for the first six months of fiscal 2007 also included approximately $4.7 million of after-tax stock-related compensation expense. Although the Companys revenues benefitted from the stronger Euro and Japanese Yen, the impact on net income for the first three and six months of fiscal 2008 was minimal as we incur considerable manufacturing and other operating expenses in our European locations.
NET SALES
Market Application
The following tables set forth, for the periods indicated, the amount of net sales and their relative percentages of total net sales by market application (dollars in thousands):
|
|
Three Months Ended |
|
||||||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
||||||
|
|
Amount |
|
Percentage |
|
Amount |
|
Percentage |
|
||
|
|
|
|
|
|
|
|
|
|
||
Consolidated: |
|
|
|
|
|
|
|
|
|
||
Microelectronics |
|
$ |
58,595 |
|
37.6 |
% |
$ |
53,768 |
|
35.3 |
% |
OEM components and instrumentation |
|
43,072 |
|
27.6 |
% |
42,548 |
|
28.0 |
% |
||
Materials processing |
|
23,381 |
|
15.0 |
% |
25,192 |
|
16.6 |
% |
||
Scientific and government programs |
|
30,894 |
|
19.8 |
% |
30,608 |
|
20.1 |
% |
||
Total |
|
$ |
155,942 |
|
100.0 |
% |
$ |
152,116 |
|
100.0 |
% |
26
|
|
Six Months Ended |
|
||||||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
||||||
|
|
Amount |
|
Percentage |
|
Amount |
|
Percentage |
|
||
|
|
|
|
|
|
|
|
|
|
||
Consolidated: |
|
|
|
|
|
|
|
|
|
||
Microelectronics |
|
$ |
107,268 |
|
35.7 |
% |
$ |
109,498 |
|
36.5 |
% |
OEM components and instrumentation |
|
84,053 |
|
28.0 |
% |
82,012 |
|
27.4 |
% |
||
Materials processing |
|
47,884 |
|
15.9 |
% |
44,566 |
|
14.9 |
% |
||
Scientific and government programs |
|
61,033 |
|
20.4 |
% |
63,549 |
|
21.2 |
% |
||
Total |
|
$ |
300,238 |
|
100.0 |
% |
$ |
299,625 |
|
100.0 |
% |
Quarterly
Net sales for the second quarter of fiscal 2008 increased by $3.8 million, or 3%, including an increase of $7.7 million due to the impact of foreign currency exchange rates, compared to the second quarter of fiscal 2007. Increases in the microelectronics, OEM components and instrumentation and scientific and government programs markets were partially offset by decreases in the materials processing market.
The increase in the microelectronics market of $4.8 million, or 9%, was primarily due to higher sales in micro material processing applications and the flat panel display market. The increase in the OEM components and instrumentation market of $0.5 million, or 1%, was due primarily to higher sales for medical and bioinstrumentation applications and increased sales for military applications, including revenues contributed by Nuvonyx (acquired in April 2007), partially offset by lower sales due to the sale of substantially all of the assets of CIOL in the fourth quarter of fiscal 2007. Scientific and government program sales increased $0.3 million, or 1%, due to higher demand for pumping, measuring and advanced research applications used by university and government research groups, partially offset by lower custom laser sales. Sales in the material processing market decreased $1.8 million, or 7%, primarily due to lower commercial laser shipments for marking applications.
Year-to-date
Net sales for the first six months of fiscal 2008 increased by $0.6 million, or less than 1%, including an increase of $11.6 million due to the impact of foreign currency exchange rates, compared to the first six months of fiscal 2007. Increases in the materials processing and OEM components and instrumentation markets were partially offset by decreases in the scientific and government programs and microelectronics markets.
Sales in the material processing market increased $3.3 million, or 7%, primarily due to higher commercial laser shipments for surface structuring and marking applications. The increase in the OEM components and instrumentation market of $2.0 million, or 2%, was due primarily to higher sales for medical and bioinstrumentation applications and increased sales for military applications, including revenues contributed by Nuvonyx (acquired in April 2007), partially offset by lower sales due to the sale of substantially all of the assets of CIOL in the fourth quarter of fiscal 2007 and lower semiconductor sales. Scientific and government program sales decreased $2.5 million, or 4%, due to lower demand for pumping, measuring and advanced research applications used by university and government research groups. The decrease in the microelectronics market of $2.2 million, or 2%, was primarily due to lower sales in the flat panel display market and in micro material processing applications.
Although we continue to have a sizeable backlog of orders, current market conditions make it difficult to predict future orders.
Segments
The following tables set forth, for the periods indicated, the amount of net sales and their relative percentages of total net sales by segment (dollars in thousands):
|
|
Three Months Ended |
|
||||||||
|
|
March 29, 2008 |
|
March 31, 2007 |
|
||||||
|
|
Amount |
|
Percentage |
|
Amount |
|
Percentage |
|
||
|
|
|
|
|
|
|
|
|
|
||
Consolidated: |
|